Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (Q81387822)
Jump to navigation
Jump to search
scientific article published on 19 October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition |
scientific article published on 19 October 2005 |
Statements
Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (English)
Tatu Juvonen
Tuula Salo
Ylermi Soini
Jani Oiva
Kariylitalo
Antti Nissinen
19 October 2005